Skip to main content
Erschienen in: Digestive Diseases and Sciences 4/2012

01.04.2012 | Original Article

The Biodurability of Covering Materials for Metallic Stents in a Bile Flow Phantom

verfasst von: Byoung Wook Bang, Seok Jeong, Don Haeng Lee, Jung Il Lee, Se Chul Lee, Sung-Gwon Kang

Erschienen in: Digestive Diseases and Sciences | Ausgabe 4/2012

Einloggen, um Zugang zu erhalten

Abstract

Background

Covered biliary metal stents have been introduced for the purpose of overcoming tumor ingrowth and treatment of benign biliary stricture. The aim of this study was to evaluate the biodurability of three commercially available biliary metal stent covering materials [e-PTFE (expanded polytetrafluoroethylene), silicone, and polyurethane] in a bile flow phantom.

Materials and Methods

By operation of a peristaltic pump, human bile was circulated continuously in an experimental perfusion system containing covered metal stents. Each stent was removed, respectively, 1, 2, 4, and 6 months after bile exposure. We performed a gross inspection of the covered stents. The covering membrane was detached from the stent and observed by scanning electron microscopy (SEM). Finally, we measured tensile and tear strength of the membranes.

Results

Bile-staining of the membrane showed gradual progression after bile exposure; however, progress was the fastest in e-PTFE. SEM examination showed that the polyurethane surface was smooth, and the silicone surface was relatively smooth. However, e-PTFE had a rough and uneven surface. After bile exposure, there were no significant changes in polyurethane and silicone; however, biofilms and microcracks were observed in e-PTFE. In contrast to a gradual decrease of tensile/tear strength of polyurethane and silicone, those of e-PTFE showed a rapid reduction despite of the strongest baseline tensile and tear strength.

Conclusion

e-PTFE tended to form biofilms more frequently than polyurethane and silicone during bile exposure. e-PTFE seemed to be less durable than silicone and polyurethane, however, as clinically applicable material because of strong absolute tensile/tear strengths.
Literatur
1.
Zurück zum Zitat Smith AC, Dowsett JF, Russell RC, Hatfield AR, Cotton PB. Randomised trial of endoscopic setting versus surgical bypass in malignant low bileduct obstruction. Lancet. 1994;344:1655–1660.PubMedCrossRef Smith AC, Dowsett JF, Russell RC, Hatfield AR, Cotton PB. Randomised trial of endoscopic setting versus surgical bypass in malignant low bileduct obstruction. Lancet. 1994;344:1655–1660.PubMedCrossRef
2.
Zurück zum Zitat Andersen JR, Sørensen SM, Kruse A, Rokkjaer M, Matzen P. Randomized trial of endoscopic endoprosthesis versus operative bypass in malignant obstruction jaundice. Gut. 1989;30:1132–1135.PubMedCrossRef Andersen JR, Sørensen SM, Kruse A, Rokkjaer M, Matzen P. Randomized trial of endoscopic endoprosthesis versus operative bypass in malignant obstruction jaundice. Gut. 1989;30:1132–1135.PubMedCrossRef
3.
Zurück zum Zitat Brountzos EN, Ptochis N, Panagiotou I, Malaqari K, Tzavara C, Kelekis D. A survival analysis of patients with malignant biliary strictures treated by percutaneous metallic stenting. Cardiovasc Intervent Radiol. 2007;30:66–73.PubMedCrossRef Brountzos EN, Ptochis N, Panagiotou I, Malaqari K, Tzavara C, Kelekis D. A survival analysis of patients with malignant biliary strictures treated by percutaneous metallic stenting. Cardiovasc Intervent Radiol. 2007;30:66–73.PubMedCrossRef
4.
Zurück zum Zitat Grandini R, Fabiano S, Pipitone V, et al. Management of biliary neoplastic obstruction with two different metallic stents implanted in one session. Cardiovasc Intervent Radiol. 2005;28:48–52.CrossRef Grandini R, Fabiano S, Pipitone V, et al. Management of biliary neoplastic obstruction with two different metallic stents implanted in one session. Cardiovasc Intervent Radiol. 2005;28:48–52.CrossRef
5.
Zurück zum Zitat Rossi P, Bezzi M, Salvatori FM, Panzetti C, Rossi M, Pavia G. Clinical experience with covered Wallstents for biliary malignancies: 23-month follow-up. Cardiovasc Intervent Radiol. 1997;20:441–447.PubMedCrossRef Rossi P, Bezzi M, Salvatori FM, Panzetti C, Rossi M, Pavia G. Clinical experience with covered Wallstents for biliary malignancies: 23-month follow-up. Cardiovasc Intervent Radiol. 1997;20:441–447.PubMedCrossRef
6.
Zurück zum Zitat Saito H, Sakurai Y, Takamura A, Horio K. Biliary endoprosthesis using Gore-Tex covered expandable metallic stents: preliminary clinical evaluation. Nippon Igaku Hoshasen Gakkai Zasshi. 1994;54:180–182.PubMed Saito H, Sakurai Y, Takamura A, Horio K. Biliary endoprosthesis using Gore-Tex covered expandable metallic stents: preliminary clinical evaluation. Nippon Igaku Hoshasen Gakkai Zasshi. 1994;54:180–182.PubMed
7.
Zurück zum Zitat Saleem A, Leggett CL, Murad MH, Baron TH. Meta-analysis of randomized trials comparing the patency of covered and uncovered self-expandable metal stents for palliation of distal malignant bile duct obstruction. Gastrointest Endosc. 2011;74:321–327.PubMedCrossRef Saleem A, Leggett CL, Murad MH, Baron TH. Meta-analysis of randomized trials comparing the patency of covered and uncovered self-expandable metal stents for palliation of distal malignant bile duct obstruction. Gastrointest Endosc. 2011;74:321–327.PubMedCrossRef
8.
Zurück zum Zitat Isayama H, Komatsu Y, Tsujino T, et al. A prospective randomised study of “covered” versus “uncovered” diamond stents for the management of distal malignant biliary obstruction. Gut. 2004;53:729–734.PubMedCrossRef Isayama H, Komatsu Y, Tsujino T, et al. A prospective randomised study of “covered” versus “uncovered” diamond stents for the management of distal malignant biliary obstruction. Gut. 2004;53:729–734.PubMedCrossRef
9.
Zurück zum Zitat Telford JJ, Carr-Locke DL, Baron TH, et al. A randomized trial comparing uncovered and partially covered self-expandable metal stents in the palliation of distal malignant biliary obstruction. Gastrointest Endosc. 2010;72:907–914.PubMedCrossRef Telford JJ, Carr-Locke DL, Baron TH, et al. A randomized trial comparing uncovered and partially covered self-expandable metal stents in the palliation of distal malignant biliary obstruction. Gastrointest Endosc. 2010;72:907–914.PubMedCrossRef
10.
Zurück zum Zitat Kullman E, Frozanpor F, Söderlund C, et al. Covered versus uncovered self-expandable nitinol stents in the palliative treatment of malignant distal biliary obstruction: results from a randomized, multicenter study. Gastrointest Endosc. 2010;72:915–923.PubMedCrossRef Kullman E, Frozanpor F, Söderlund C, et al. Covered versus uncovered self-expandable nitinol stents in the palliative treatment of malignant distal biliary obstruction: results from a randomized, multicenter study. Gastrointest Endosc. 2010;72:915–923.PubMedCrossRef
11.
Zurück zum Zitat Kanasaki S, Furukawa A, Kane T, Murata K. Polyurethane-covered nitinol Strecker stents as primary palliative treatment of malignant biliary obstruction. Cardiovasc Intervent Radiol. 2000;23:114–120.PubMedCrossRef Kanasaki S, Furukawa A, Kane T, Murata K. Polyurethane-covered nitinol Strecker stents as primary palliative treatment of malignant biliary obstruction. Cardiovasc Intervent Radiol. 2000;23:114–120.PubMedCrossRef
12.
Zurück zum Zitat Maccinoni F, Rossi M, Salvatori FM, Ricci P, Bezzi M, Rossi P. Metallic stents in benign biliary stricture: three-year follow-up. Cardiovasc Intervent Radiol. 1992;15:360–366.CrossRef Maccinoni F, Rossi M, Salvatori FM, Ricci P, Bezzi M, Rossi P. Metallic stents in benign biliary stricture: three-year follow-up. Cardiovasc Intervent Radiol. 1992;15:360–366.CrossRef
13.
Zurück zum Zitat Yoon HK, Sung KB, Song HY, et al. Benign biliary strictures associated with recurrent pyogenic changitis: treatment with expandable metallic stents. Am J Roentgenol. 1997;169:1523–1527. Yoon HK, Sung KB, Song HY, et al. Benign biliary strictures associated with recurrent pyogenic changitis: treatment with expandable metallic stents. Am J Roentgenol. 1997;169:1523–1527.
14.
Zurück zum Zitat Behm B, Brock A, Clarke BW, et al. Partially covered self-expandable metallic stents for benign biliary strictures due to chronic pancreatitis. Endoscopiy. 2009;41:547–551.CrossRef Behm B, Brock A, Clarke BW, et al. Partially covered self-expandable metallic stents for benign biliary strictures due to chronic pancreatitis. Endoscopiy. 2009;41:547–551.CrossRef
15.
Zurück zum Zitat Hausegger KA, Thurnher S, Bodendorfer G, et al. Treatment of malignant biliary obstruction with polyurethane covered Wallstents. Am J Roentgenol. 1998;170:403–408. Hausegger KA, Thurnher S, Bodendorfer G, et al. Treatment of malignant biliary obstruction with polyurethane covered Wallstents. Am J Roentgenol. 1998;170:403–408.
16.
Zurück zum Zitat Kim DH, Kang SG, Choi JR, Byun JN, Kim YC, Ahn YM. Evaluation of the biodurability of polyurethane-covered stent using a flow phantom. Korean J Radiol. 2001;2:75–79.PubMedCrossRef Kim DH, Kang SG, Choi JR, Byun JN, Kim YC, Ahn YM. Evaluation of the biodurability of polyurethane-covered stent using a flow phantom. Korean J Radiol. 2001;2:75–79.PubMedCrossRef
17.
Zurück zum Zitat Severini A, Mantero S, Tanzi MC, et al. In vivo study of polyurethane-coated Gianturco-Rosch biliary Z-stents. Cardiovasc Intervent Radiol. 1999;22:510–514.PubMedCrossRef Severini A, Mantero S, Tanzi MC, et al. In vivo study of polyurethane-coated Gianturco-Rosch biliary Z-stents. Cardiovasc Intervent Radiol. 1999;22:510–514.PubMedCrossRef
18.
Zurück zum Zitat Yasumori K, Mahmoudi N, Wright KC, Wallace S, Gianturco C. Placement of covered self-expanding metallic stents in the common bile duct: a feasibility study. J Vasc Interv Radiol. 1993;4:773–778.PubMedCrossRef Yasumori K, Mahmoudi N, Wright KC, Wallace S, Gianturco C. Placement of covered self-expanding metallic stents in the common bile duct: a feasibility study. J Vasc Interv Radiol. 1993;4:773–778.PubMedCrossRef
19.
Zurück zum Zitat Baron TH. Palliation of malignant obstructive jaundice. Gastroenterol Clin North Am. 2006;35:101–112.PubMedCrossRef Baron TH. Palliation of malignant obstructive jaundice. Gastroenterol Clin North Am. 2006;35:101–112.PubMedCrossRef
20.
Zurück zum Zitat Guaglianone E, Cardines R, Vuotto C, et al. Microbial biofilmes associated with biliary stent clogging. FEMS Immunol Med Microbiol. 2010;59:410–420.PubMed Guaglianone E, Cardines R, Vuotto C, et al. Microbial biofilmes associated with biliary stent clogging. FEMS Immunol Med Microbiol. 2010;59:410–420.PubMed
21.
Zurück zum Zitat Hirabayashi K, Saitoh H, Ijima H, Takenawa T, Kodama M, Hori M. Influence of fibril length upon ePTFE graft healing and host modification of the implant. J Biomed Mater Res. 1992;26:1433–1447.PubMedCrossRef Hirabayashi K, Saitoh H, Ijima H, Takenawa T, Kodama M, Hori M. Influence of fibril length upon ePTFE graft healing and host modification of the implant. J Biomed Mater Res. 1992;26:1433–1447.PubMedCrossRef
22.
Zurück zum Zitat Hatzidakis A, Krokidis M, Kalbakis K, Romanos J, Petrakis I, Gourtsoyiannis N. ePTFE/FEP-covered metallic stents for palliation of malignant biliary disease: can tumor ingrowth be prevented? Cardiovasc Intervent Radiol. 2007;30:950–958.PubMedCrossRef Hatzidakis A, Krokidis M, Kalbakis K, Romanos J, Petrakis I, Gourtsoyiannis N. ePTFE/FEP-covered metallic stents for palliation of malignant biliary disease: can tumor ingrowth be prevented? Cardiovasc Intervent Radiol. 2007;30:950–958.PubMedCrossRef
23.
Zurück zum Zitat Gwon DI, Ko GY, Kim JH, et al. A comparative analysis of PTFE-covered and uncovered stents for palliative treatment of malignant extrahepatic biliary obstruction. Am J Roentgenol. 2010;195:463–469.CrossRef Gwon DI, Ko GY, Kim JH, et al. A comparative analysis of PTFE-covered and uncovered stents for palliative treatment of malignant extrahepatic biliary obstruction. Am J Roentgenol. 2010;195:463–469.CrossRef
24.
Zurück zum Zitat Khan I, Smith N, Jones E, Finch DS, Cameron RE. Analysis and evaluation of a biomedical polycarbonate urethane tested in an in vitro study and an ovine arthroplasty model. Part I: materials selection and evaluation. Biomaterials. 2005;26:621–631.PubMedCrossRef Khan I, Smith N, Jones E, Finch DS, Cameron RE. Analysis and evaluation of a biomedical polycarbonate urethane tested in an in vitro study and an ovine arthroplasty model. Part I: materials selection and evaluation. Biomaterials. 2005;26:621–631.PubMedCrossRef
Metadaten
Titel
The Biodurability of Covering Materials for Metallic Stents in a Bile Flow Phantom
verfasst von
Byoung Wook Bang
Seok Jeong
Don Haeng Lee
Jung Il Lee
Se Chul Lee
Sung-Gwon Kang
Publikationsdatum
01.04.2012
Verlag
Springer US
Erschienen in
Digestive Diseases and Sciences / Ausgabe 4/2012
Print ISSN: 0163-2116
Elektronische ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-011-1958-6

Weitere Artikel der Ausgabe 4/2012

Digestive Diseases and Sciences 4/2012 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.